Results 10,841-10,860 of 12,718 for speaker:Louise O'Reilly

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Louise O'Reilly: It has announced it.

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Louise O'Reilly: Has Mr. O'Brien any estimate of what it could cost if they won their case?

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Louise O'Reilly: Will that encompass the 68 children in question?

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Louise O'Reilly: Are there plans to run the theatre in Crumlin on a five-day basis?

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Louise O'Reilly: Is the HSE confident it will hit the targets by the end of the year?

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Louise O'Reilly: Did Mr. O'Brien instruct the section 39 agencies at the time when the funding was cut that they should cut the pay of their staff either implicitly or explicitly? I took several cases to the Labour Court in relation to that and the feeling at the time was that they were following HSE and Department of Health advice.

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Louise O'Reilly: Bed occupancy rates of 100% or more spread infection, distress staff and are dangerous. As Mr. O'Brien pointed out, a bed occupancy rate of 85% is the norm.

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Louise O'Reilly: I will ask a number of brief questions, to which I hope I will receive long, detailed answers. I am seeking a breakdown of the funding in the mental health division that will be used to cover the cost of agency staff and external placements - people who are not being looked after in the service but for whom care costs are being paid. Key performance indicators have been set for the cancer...

Joint Oireachtas Committee on Health: Quarterly Update On Health Issues: Discussion (18 Oct 2017)

Louise O'Reilly: Is there an estimated timeframe for their completion?

Written Answers — Department of Defence: Defence Forces Review (18 Oct 2017)

Louise O'Reilly: 54. To ask the Taoiseach and Minister for Defence the way he plans to address the issues of manning levels and retention of experience in the Defence Forces as identified by the University of Limerick in its focus group report 2017; his views on claims from military sources that the reduction in training periods was diluting the professionalism of the Defence Forces; and if the current...

Written Answers — Department of Defence: Defence Forces Medicinal Products (18 Oct 2017)

Louise O'Reilly: 59. To ask the Taoiseach and Minister for Defence the efforts which have been made to withdraw and replace the anti-malaria drug Lariam and implement the proposals contained in the cross-party motion that was passed in the previous Dáil Éireann term; and if he will make a statement on the matter. [44035/17]

Written Answers — Department of Health: Medicinal Products Availability (18 Oct 2017)

Louise O'Reilly: 146. To ask the Minister for Health his plans to make long acting reversible contraception available to all medical card holders; and if he will make a statement on the matter. [44145/17]

Written Answers — Department of Health: Medical Products (18 Oct 2017)

Louise O'Reilly: 154. To ask the Minister for Health the number of persons who have received a transvaginal mesh implant procedure through the HSE; and if he will make a statement on the matter. [44268/17]

Written Answers — Department of Health: Medical Products (18 Oct 2017)

Louise O'Reilly: 155. To ask the Minister for Health the number of transvaginal mesh implant procedures carried out here, by year, in tabular form; and if he will make a statement on the matter. [44269/17]

Written Answers — Department of Health: Medical Products (18 Oct 2017)

Louise O'Reilly: 156. To ask the Minister for Health the number of women who received transvaginal mesh implant procedures and who are now taking legal action against the HSE or the State; and if he will make a statement on the matter. [44270/17]

Written Answers — Department of Health: Medical Products (18 Oct 2017)

Louise O'Reilly: 157. To ask the Minister for Health when his attention was drawn to the side effects and complications of transvaginal mesh implant procedures; the steps he took to address the situation; and if he will make a statement on the matter. [44271/17]

Written Answers — Department of Health: Medicinal Products Availability (17 Oct 2017)

Louise O'Reilly: 289. To ask the Minister for Health if there have been issues for persons travelling abroad in accessing vaccines for hepatitis A and typhoid, in particular the ViATIM and Hepatyrix vaccines; and if he will make a statement on the matter. [43483/17]

Written Answers — Department of Health: Services for People with Disabilities (17 Oct 2017)

Louise O'Reilly: 348. To ask the Minister for Health if his attention has been drawn to the alarm among disabled persons and their families and carers in County Donegal, caused by the closure of the swimming pool at a location (details supplied); if the swimming pool will be reopened; and if he will make a statement on the matter. [43713/17]

Written Answers — Department of Health: Obesity Strategy (17 Oct 2017)

Louise O'Reilly: 378. To ask the Minister for Health when the food reformulation working group will be established; when the membership will be determined; if public health organisations will be involved; when the draft terms of reference will be prepared for this technical group; when it will be convened; and if he will make a statement on the matter. [43889/17]

Written Answers — Department of Health: Obesity Strategy (17 Oct 2017)

Louise O'Reilly: 379. To ask the Minister for Health the way the reformulation efforts will be monitored in view of the introduction of the sugar sweetened drinks tax in April 2018; the role the FSAI will have in this; and if he will make a statement on the matter. [43890/17]